The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions.If you have any queries about the SPCs on our website then please e-mail vetinfo@hpra.ie


Versican Plus BbPi IN nasal drops, lyophilisate and solvent for suspension for dogs

. Lyophilisate and solvent for suspension for nasal administration

Zoetis Belgium S.A.VPA10387/098/001

Main Information

Trade NameVersican Plus BbPi IN nasal drops, lyophilisate and solvent for suspension for dogs
Active SubstancesBordetella bronchiseptica, live
Canine parainfluenza virus, live
Strength.
Dosage FormLyophilisate and solvent for suspension for nasal administration
Licence HolderZoetis Belgium S.A.
Licence NumberVPA10387/098/001

Group Information

ATC CodeQI07AF01 bordetella + canine parainfluenza virus
Therapeutic ClassImmunological - Live Vaccine
SpeciesDogs

Status

Authorised/WithdrawnAuthorised
Licence Issued25/08/2020
Legal StatusPOM: Prescription Only Medicine as defined in relevant national legislation

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back